Scott A. Gangloff

Companies

• Akero Therapeutics, Inc.Chief Technology Officer May 1, 2024 to now¹
• Outlook Therapeutics, Inc.SVP, Development & Mfrg May 12, 2016 to Dec 22, 2016²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ATAkero Therapeutics, Inc.0 shares³Dec 9, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Dec 9, 2025Returned to company 21,263 shares of Akero Therapeutics, Inc.³
• Dec 9, 2025Returned to company 5,088 shares of Akero Therapeutics, Inc.³
• Aug 15, 2025Exercised options 2,600 shares at $19.62 of Akero Therapeutics, Inc.⁴
• Jun 30, 2025Granted 299 shares at $23.87 of Akero Therapeutics, Inc.⁵
• Jun 18, 2025Sold 848 shares at $54.84 of Akero Therapeutics, Inc.⁶
• Dec 16, 2024Granted 24,300 shares of Akero Therapeutics, Inc.⁷